224 related articles for article (PubMed ID: 37834179)
1. Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models.
Payá-Milans M; Peña-Chilet M; Loucera C; Esteban-Medina M; Dopazo J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834179
[TBL] [Abstract][Full Text] [Related]
2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract][Full Text] [Related]
3. Dissociation protocols used for sarcoma tissues bias the transcriptome observed in single-cell and single-nucleus RNA sequencing.
Truong DD; Lamhamedi-Cherradi SE; Porter RW; Krishnan S; Swaminathan J; Gibson A; Lazar AJ; Livingston JA; Gopalakrishnan V; Gordon N; Daw NC; Navin NE; Gorlick R; Ludwig JA
BMC Cancer; 2023 May; 23(1):488. PubMed ID: 37254069
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive profiling of immune-related genes in soft tissue sarcoma patients.
Hu C; Chen B; Huang Z; Liu C; Ye L; Wang C; Tong Y; Yang J; Zhao C
J Transl Med; 2020 Sep; 18(1):337. PubMed ID: 32873319
[TBL] [Abstract][Full Text] [Related]
5. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.
Qi L; Zhang W; Ren X; Xu R; Yang Z; Chen R; Tu C; Li Z
Front Immunol; 2022; 13():921223. PubMed ID: 35860263
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome Analysis of Tumor-Infiltrating Lymphocytes Identifies NK Cell Gene Signatures Associated With Lymphocyte Infiltration and Survival in Soft Tissue Sarcomas.
Judge SJ; Bloomstein JD; Sholevar CJ; Darrow MA; Stoffel KM; Vick LV; Dunai C; Cruz SM; Razmara AM; Monjazeb AM; Rebhun RB; Murphy WJ; Canter RJ
Front Immunol; 2022; 13():893177. PubMed ID: 35874727
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA-seq of a soft-tissue sarcoma model reveals the critical role of tumor-expressed MIF in shaping macrophage heterogeneity.
Tessaro FHG; Ko EY; De Simone M; Piras R; Broz MT; Goodridge HS; Balzer B; Shiao SL; Guarnerio J
Cell Rep; 2022 Jun; 39(12):110977. PubMed ID: 35732118
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential prognostic small nucleolar RNA biomarkers for predicting overall survival in patients with sarcoma.
Liu J; Liao X; Zhu X; Lv P; Li R
Cancer Med; 2020 Oct; 9(19):7018-7033. PubMed ID: 32780509
[TBL] [Abstract][Full Text] [Related]
10. Comparative whole transcriptome analysis of gene expression in three canine soft tissue sarcoma types.
Lam L; Tien T; Wildung M; White L; Sellon RK; Fidel JL; Shelden EA
PLoS One; 2022; 17(9):e0273705. PubMed ID: 36099287
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
[TBL] [Abstract][Full Text] [Related]
12. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone.
Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F
J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149
[TBL] [Abstract][Full Text] [Related]
13. Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients.
Wang Y; Li J; Shao C; Tang X; Du Y; Xu T; Zhao Z; Hu H; Sheng Y; Hu C; Xi Y
BMC Cancer; 2021 Jan; 21(1):58. PubMed ID: 33435917
[TBL] [Abstract][Full Text] [Related]
14. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
16. PLCG2 as a potential indicator of tumor microenvironment remodeling in soft tissue sarcoma.
Li Z; Zhao R; Yang W; Li C; Huang J; Wen Z; Du G; Jiang L
Medicine (Baltimore); 2021 Mar; 100(11):e25008. PubMed ID: 33725976
[TBL] [Abstract][Full Text] [Related]
17. Identification of Prognostic lncRNA Related to the Immune Microenvironment of Soft Tissue Sarcoma.
Dai WY; Wang B; Li JY; Luo ZP
Biomed Res Int; 2022; 2022():9471558. PubMed ID: 35155682
[TBL] [Abstract][Full Text] [Related]
18. Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma.
Que Y; Zhang XL; Liu ZX; Zhao JJ; Pan QZ; Wen XZ; Xiao W; Xu BS; Hong DC; Guo TH; Shen LJ; Fan WJ; Chen HY; Weng DS; Xu HR; Zhou PH; Zhang YZ; Niu XH; Zhang X
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637599
[TBL] [Abstract][Full Text] [Related]
19. Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile.
Hofvander J; Puls F; Pillay N; Steele CD; Flanagan AM; Magnusson L; Nilsson J; Mertens F
J Pathol; 2019 Dec; 249(4):425-434. PubMed ID: 31313299
[TBL] [Abstract][Full Text] [Related]
20. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
